Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.

Swietlik EM, Ruggiero A, Fletcher AJ, Taboada D, Knightbridge E, Harlow L, Harvey I, Screaton N, Cannon JE, Sheares KKK, Ng C, Jenkins DP, Pepke-Zaba J, Toshner MR.

Eur Respir J. 2018 Nov 8. pii: 1801787. doi: 10.1183/13993003.01787-2018. [Epub ahead of print] No abstract available.

PMID:
30409818
2.

A readability analysis of online mental health resources.

Skierkowski DD, Florin P, Harlow LL, Machan J, Ye Y.

Am Psychol. 2018 Oct 8. doi: 10.1037/amp0000324. [Epub ahead of print]

PMID:
30299121
3.

Alterations in mitochondrial fission, fusion, and mitophagic protein expression in the gastrocnemius of mice after a sciatic nerve transection.

Graham ZA, Harlow L, Bauman WA, Cardozo CP.

Muscle Nerve. 2018 Oct;58(4):592-599. doi: 10.1002/mus.26197. Epub 2018 Sep 3.

PMID:
30028528
4.

Creation and validation of the barriers to alcohol reduction (BAR) scale using classical test theory and item response theory.

Kunicki ZJ, Schick MR, Spillane NS, Harlow LL.

Addict Behav Rep. 2018 Jan 28;7:47-52. doi: 10.1016/j.abrep.2018.01.004. eCollection 2018 Jun.

5.

Denervation-related alterations and biological activity of miRNAs contained in exosomes released by skeletal muscle fibers.

De Gasperi R, Hamidi S, Harlow LM, Ksiezak-Reding H, Bauman WA, Cardozo CP.

Sci Rep. 2017 Oct 16;7(1):12888. doi: 10.1038/s41598-017-13105-9.

6.

Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization-induced bone loss.

Harlow L, Sahbani K, Nyman JS, Cardozo CP, Bauman WA, Tawfeek HA.

Physiol Rep. 2017 Sep;5(18). pii: e13446. doi: 10.14814/phy2.13446. Epub 2017 Sep 27.

7.

Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension.

Hernández-Sánchez J, Harlow L, Church C, Gaine S, Knightbridge E, Bunclark K, Gor D, Bedding A, Morrell N, Corris P, Toshner M.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217735820. doi: 10.1177/2045893217735820. Epub 2017 Sep 28.

PMID:
28956500
8.

Modeling multiple health behaviors and general health.

Ufholz KE, Harlow LL.

Prev Med. 2017 Dec;105:127-134. doi: 10.1016/j.ypmed.2017.08.003. Epub 2017 Sep 8.

PMID:
28893595
9.

Reporting Practices and Use of Quantitative Methods in Canadian Journal Articles in Psychology.

Counsell A, Harlow LL.

Can Psychol. 2017 May;58(2):140-147. doi: 10.1037/cap0000074. Epub 2016 Oct 6.

10.

Identifying seizure clusters in patients with psychogenic nonepileptic seizures.

Baird GL, Harlow LL, Machan JT, Thomas D, LaFrance WC Jr.

Epilepsy Behav. 2017 Aug;73:142-147. doi: 10.1016/j.yebeh.2017.04.040. Epub 2017 Jul 18.

PMID:
28641165
11.

Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures.

Baird GL, Harlow LL, Machan JT, LaFrance WC Jr.

Epilepsy Behav. 2017 Aug;73:273-279. doi: 10.1016/j.yebeh.2017.04.015. Epub 2017 Jun 16.

PMID:
28624511
12.

Intervention Effects on Stage of Change Membership and Transitions among Adolescent Energy Balance Behaviors.

Brick LA, Redding CA, Paiva AL, Harlow LL, Velicer WF.

Multivariate Behav Res. 2017 Jul-Aug;52(4):485-498. doi: 10.1080/00273171.2017.1309518. Epub 2017 Apr 20.

PMID:
28426252
13.

The making of Psychological Methods.

Harlow LL.

Psychol Methods. 2017 Mar;22(1):1-5. doi: 10.1037/met0000141.

14.

Increasing Literacy in Quantitative Methods: The Key to the Future of Canadian Psychology.

Counsell A, Cribbie RA, Harlow LL.

Can Psychol. 2016 Aug;57(3):193-201. doi: 10.1037/cap0000056.

15.

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines.

Coxon CR, Anscombe E, Harnor SJ, Martin MP, Carbain B, Golding BT, Hardcastle IR, Harlow LK, Korolchuk S, Matheson CJ, Newell DR, Noble ME, Sivaprakasam M, Tudhope SJ, Turner DM, Wang LZ, Wedge SR, Wong C, Griffin RJ, Endicott JA, Cano C.

J Med Chem. 2017 Mar 9;60(5):1746-1767. doi: 10.1021/acs.jmedchem.6b01254. Epub 2017 Feb 14.

16.

Spinal Cord Injury Leads to Hyperoxidation and Nitrosylation of Skeletal Muscle Ryanodine Receptor-1 Associated with Upregulation of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4.

Liu XH, Harlow L, Graham ZA, Bauman WA, Cardozo C.

J Neurotrauma. 2017 Jun 15;34(12):2069-2074. doi: 10.1089/neu.2016.4763. Epub 2017 Feb 27.

PMID:
27998200
17.

Big data in psychology: Introduction to the special issue.

Harlow LL, Oswald FL.

Psychol Methods. 2016 Dec;21(4):447-457.

18.

The Signature of MicroRNA Dysregulation in Muscle Paralyzed by Spinal Cord Injury Includes Downregulation of MicroRNAs that Target Myostatin Signaling.

De Gasperi R, Graham ZA, Harlow LM, Bauman WA, Qin W, Cardozo CP.

PLoS One. 2016 Dec 1;11(12):e0166189. doi: 10.1371/journal.pone.0166189. eCollection 2016.

19.

Longitudinal analysis of intervention effects on temptations and stages of change for dietary fat using parallel process latent growth modeling.

Brick LAD, Yang S, Harlow LL, Redding CA, Prochaska JO.

J Health Psychol. 2016 Nov 1:1359105316679723. doi: 10.1177/1359105316679723. [Epub ahead of print]

20.

Improving Health of At-Risk Rural Patients project: A collaborative care model.

Matzke GR, Czar MJ, Lee WT, Moczygemba LR, Harlow LD.

Am J Health Syst Pharm. 2016 Nov 1;73(21):1760-1768. Epub 2016 Sep 19.

PMID:
27646406
21.

Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes.

Travers TS, Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Bhattacharya SK, Camacho CJ, Ascherman DP.

J Immunol. 2016 Sep 1;197(5):1926-36. doi: 10.4049/jimmunol.1600162. Epub 2016 Jul 22.

22.

Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.

Qin W, Zhao W, Li X, Peng Y, Harlow LM, Li J, Qin Y, Pan J, Wu Y, Ran L, Ke HZ, Cardozo CP, Bauman WA.

Osteoporos Int. 2016 Dec;27(12):3627-3636. Epub 2016 Jul 20.

PMID:
27436301
23.

Sclerostin Antibody Preserves the Morphology and Structure of Osteocytes and Blocks the Severe Skeletal Deterioration After Motor-Complete Spinal Cord Injury in Rats.

Qin W, Li X, Peng Y, Harlow LM, Ren Y, Wu Y, Li J, Qin Y, Sun J, Zheng S, Brown T, Feng JQ, Ke HZ, Bauman WA, Cardozo CP.

J Bone Miner Res. 2016 Jul;31(7):1482. doi: 10.1002/jbmr.2864. Epub 2016 Jun 8. No abstract available.

24.

Focal adhesion kinase signaling is decreased 56 days following spinal cord injury in rat gastrocnemius.

Graham ZA, Qin W, Harlow LC, Ross NH, Bauman WA, Gallagher PM, Cardozo CP.

Spinal Cord. 2016 Jul;54(7):502-9. doi: 10.1038/sc.2015.183. Epub 2015 Oct 20.

PMID:
26481700
25.

Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats.

Qin W, Li X, Peng Y, Harlow LM, Ren Y, Wu Y, Li J, Qin Y, Sun J, Zheng S, Brown T, Feng JQ, Ke HZ, Bauman WA, Cardozo CC.

J Bone Miner Res. 2015 Nov;30(11):1994-2004. doi: 10.1002/jbmr.2549. Epub 2015 Jun 10. Erratum in: J Bone Miner Res. 2016 Jul;31(7):1482.

26.

Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses.

Harlow L, Gochuico BR, Rosas IO, Doyle TJ, Osorio JC, Travers TS, Camacho CC, Oddis CV, Ascherman DP.

Clin Immunol. 2014 Nov;155(1):60-70. doi: 10.1016/j.clim.2014.08.004. Epub 2014 Aug 19.

27.

A Meta-View of Multivariate Statistical Inference Methods in European Psychology Journals.

Harlow LL, Korendijk E, Hamaker EL, Hox J, Duerr SR.

Multivariate Behav Res. 2013 Sep;48(5):749-74. doi: 10.1080/00273171.2013.822784.

PMID:
26741061
28.

Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.

Fernandez I, Harlow L, Zang Y, Liu-Bryan R, Ridgway WM, Clemens PR, Ascherman DP.

J Immunol. 2013 Aug 15;191(4):1865-72. doi: 10.4049/jimmunol.1203070. Epub 2013 Jul 10.

29.

Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.

Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Dellaripa PF, Oddis CV, Ascherman DP.

Arthritis Rheum. 2013 Apr;65(4):869-79. doi: 10.1002/art.37881.

30.

Abstract: Multisample Latent Variable Model of Math Achievement Across International Country Clusters.

Duerr SR, Harlow LL.

Multivariate Behav Res. 2013 Jan;48(1):155-6. doi: 10.1080/00273171.2012.748363. No abstract available.

PMID:
26789218
31.

Characterization of TLR4-mediated auto-antibody production in a mouse model of histidyl-tRNA synthetase-induced myositis.

Harlow L, Fernandez I, Soejima M, Ridgway WM, Ascherman DP.

Innate Immun. 2012 Dec;18(6):876-85. doi: 10.1177/1753425912446714. Epub 2012 May 11.

PMID:
22582345
32.

Examining findings from the National State of the Home Care Industry Study.

Fazzi R, Ashe T, Harlow L.

Caring. 2010 Jan;29(1):30-2. No abstract available.

PMID:
20184230
33.

Controlling the future: the Philips National Chronic Disease Project.

Fazzi R, Ashe T, Harlow L.

Caring. 2009 Jan;28(1):38-44. No abstract available.

PMID:
19266753
34.

Associations of Sexual Victimization, Depression, and Sexual Assertiveness with Unprotected Sex: A Test of the Multifaceted Model of HIV Risk Across Gender.

Morokoff PJ, Redding CA, Harlow LL, Cho S, Rossi JS, Meier KS, Mayer KH, Koblin B, Brown-Peterside P.

J Appl Biobehav Res. 2009 Jan;14(1):30-54.

35.

Home care and chronic disease: the untold story.

Fazzi R, Ashe T, Harlow L.

Caring. 2008 Oct;27(10):8-12. No abstract available.

PMID:
18982847
36.

The incredible future of home care and hospice.

Fazzi R, Harlow L.

Caring. 2007 Mar;26(3):36-8, 40-5. No abstract available.

PMID:
17715855
37.

Want your agency to thrive? Remember the reality of one point five.

Fazzi R, Harlow L.

Caring. 2007 Feb;26(2):60-1. No abstract available.

PMID:
17370906
38.

Effect of C-terminal of human cytosolic thymidine kinase (TK1) on in vitro stability and enzymatic properties.

Zhu C, Harlow LS, Berenstein D, Munch-Petersen S, Munch-Petersen B.

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1185-8.

PMID:
17065087
39.

Applying the transtheoretical model to ethnically diverse women at risk for HIV.

Gazabon SA, Morokoff PJ, Harlow LL, Ward RM, Quina K.

Health Educ Behav. 2007 Apr;34(2):297-314. Epub 2006 May 31. Erratum in: Health Educ Behav. 2007 Jun;34(3):551.

PMID:
16740521
40.

A measurement model of women's behavioral risk taking.

VanZile-Tamsen C, Testa M, Harlow LL, Livingston JA.

Health Psychol. 2006 Mar;25(2):249-54.

41.

Mechanism by which H-2g, a glucose analog of blood group H antigen, mediates angiogenesis.

Zhu K, Amin MA, Zha Y, Harlow LA, Koch AE.

Blood. 2005 Mar 15;105(6):2343-9. Epub 2004 Oct 21.

42.
43.

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE.

Circ Res. 2003 Aug 22;93(4):321-9. Epub 2003 Jul 24.

PMID:
12881477
44.

Assessing the transtheoretical model of change constructs for physicians counseling smokers.

Park ER, DePue JD, Goldstein MG, Niaura R, Harlow LL, Willey C, Rakowski W, Prokhorov AV.

Ann Behav Med. 2003 Spring;25(2):120-6.

PMID:
12704014
45.

Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis.

Kumar P, Amin MA, Harlow LA, Polverini PJ, Koch AE.

Blood. 2003 May 15;101(10):3960-8. Epub 2003 Jan 9.

46.

Operational benchmarks. What CEOs want (need) to know.

Fazzi RA, Agoglia RV, Harlow L.

Caring. 2002 Nov;21(11):40-3.

PMID:
12436899
47.

Benchmarking. It's the future.

Fazzi RA, Agoglia RV, Harlow L.

Caring. 2002 Nov;21(11):36-9.

PMID:
12436898
48.

Spirituality, demographic and disease factors, and adjustment to cancer.

Schnoll RA, Harlow LL, Brower L.

Cancer Pract. 2000 Nov-Dec;8(6):298-304.

PMID:
11898147
49.

Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.

Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE.

Am J Pathol. 2001 Oct;159(4):1521-30.

50.

Evidence of IL-18 as a novel angiogenic mediator.

Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE.

J Immunol. 2001 Aug 1;167(3):1644-53.

Supplemental Content

Loading ...
Support Center